Tenaya Therapeutics, Inc. Other Nonoperating Income (Expense)
Tenaya Therapeutics, Inc. (TNYA) reported Other Nonoperating Income (Expense) of -$2.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-05
- Tenaya Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was -$2.00K.
- Tenaya Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was $25.00K, a 525.00% increase year-over-year.
- Tenaya Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was $3.00K.
- Tenaya Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2025-06-30 was -$16.00K.
- Tenaya Therapeutics, Inc. other nonoperating income (expense) for fiscal 2025 was $52.00K, a 36.59% decline from fiscal 2024.
- Tenaya Therapeutics, Inc. other nonoperating income (expense) for fiscal 2024 was $82.00K, a 54.72% increase from fiscal 2023.
- Tenaya Therapeutics, Inc. other nonoperating income (expense) for fiscal 2023 was $53.00K, a 2550.00% increase from fiscal 2022.
- Tenaya Therapeutics, Inc. other nonoperating income (expense) for fiscal 2022 was $2.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.00K 10-Q · filed 2026-08-05 | -$2.00K 10-Q · filed 2026-08-05 | ||
| 2025-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $28.00K derived: sum of 2 quarters · filed 2026-03-11 | $12.00K derived: sum of 3 quarters · filed 2026-08-05 | $52.00K 10-K · filed 2026-03-11 |
| 2025-09-30 | $3.00K 10-Q · filed 2025-11-10 | -$13.00K derived: sum of 2 quarters · filed 2026-08-05 | $27.00K 10-Q · filed 2025-11-10 | $30.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$16.00K 10-Q · filed 2026-08-05 | $24.00K 10-Q · filed 2026-08-05 | $27.00K derived: sum of 3 quarters · filed 2026-08-05 | $24.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $39.00K 10-Q · filed 2026-05-06 | $43.00K derived: sum of 2 quarters · filed 2026-05-06 | $40.00K derived: sum of 3 quarters · filed 2026-05-06 | $39.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $1.00K derived: sum of 2 quarters · filed 2026-03-11 | $0.00 derived: sum of 3 quarters · filed 2026-03-11 | $82.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | -$3.00K 10-Q · filed 2025-11-10 | -$4.00K derived: sum of 2 quarters · filed 2025-11-10 | $78.00K 10-Q · filed 2025-11-10 | $119.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$1.00K 10-Q · filed 2025-08-06 | $81.00K 10-Q · filed 2025-08-06 | $122.00K derived: sum of 3 quarters · filed 2025-08-06 | $123.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $82.00K 10-Q · filed 2025-05-07 | $123.00K derived: sum of 2 quarters · filed 2025-05-07 | $124.00K derived: sum of 3 quarters · filed 2025-05-07 | $122.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $42.00K derived: sum of 2 quarters · filed 2025-03-10 | $40.00K derived: sum of 3 quarters · filed 2025-03-10 | $53.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $1.00K 10-Q · filed 2024-11-06 | -$1.00K derived: sum of 2 quarters · filed 2024-11-06 | $12.00K 10-Q · filed 2024-11-06 | $9.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$2.00K 10-Q · filed 2024-08-08 | $11.00K 10-Q · filed 2024-08-08 | $8.00K derived: sum of 3 quarters · filed 2024-08-08 | $14.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $13.00K 10-Q · filed 2024-05-14 | $10.00K derived: sum of 2 quarters · filed 2024-05-14 | $16.00K derived: sum of 3 quarters · filed 2024-05-14 | $16.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $3.00K derived: sum of 2 quarters · filed 2024-03-18 | $3.00K derived: sum of 3 quarters · filed 2024-03-18 | $2.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $6.00K 10-Q · filed 2023-11-08 | $6.00K derived: sum of 2 quarters · filed 2023-11-08 | $5.00K 10-Q · filed 2023-11-08 | -$49.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.00K 10-Q · filed 2023-08-09 | -$55.00K derived: sum of 3 quarters · filed 2023-08-09 | -$40.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$1.00K 10-Q · filed 2023-05-10 | -$55.00K derived: sum of 2 quarters · filed 2023-05-10 | -$40.00K derived: sum of 3 quarters · filed 2023-05-10 | -$22.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$39.00K derived: sum of 2 quarters · filed 2023-03-08 | -$21.00K derived: sum of 3 quarters · filed 2023-03-08 | -$23.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | $15.00K 10-Q · filed 2022-11-10 | $33.00K derived: sum of 2 quarters · filed 2022-11-10 | $31.00K 10-Q · filed 2022-11-10 | $30.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $18.00K 10-Q · filed 2022-08-10 | $16.00K 10-Q · filed 2022-08-10 | $15.00K derived: sum of 3 quarters · filed 2022-08-10 | $14.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$2.00K 10-Q · filed 2022-05-11 | -$3.00K derived: sum of 2 quarters · filed 2022-05-11 | -$4.00K derived: sum of 3 quarters · filed 2022-05-11 | $176.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$2.00K derived: sum of 2 quarters · filed 2022-03-23 | $178.00K derived: sum of 3 quarters · filed 2022-03-23 | $355.00K 10-K · filed 2022-03-23 |
| 2020-09-30 | -$1.00K 10-Q · filed 2021-11-10 | $179.00K derived: sum of 2 quarters · filed 2021-11-10 | $356.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $180.00K 10-Q · filed 2021-09-08 | $357.00K 10-Q · filed 2021-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |